• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home » News »
  • Home loans: A look at lenders offering lowest interest rates

    SBI has announced 100% waiver on processing fees on home loans until August 31 for all customers

    Ankur SenguptaAugust 2, 2021/5:36 PM IST
  • RIL, Infosys lift Sensex by 364 points, Nifty ends above 15,850

    Sensex rallied 363.79 points or 0.69% to end at 52,950.63, while the broader NSE Nifty surged 122.10 points or 0.77% to 15,885.15

    Money9August 2, 2021/5:10 PM IST
  • After a second Olympic medal, PV Sindhu deserves Bharat Ratna

    Only the fourth player to win two consecutive medals in women’s badminton singles at Olympics, a Bharat Ratna would be a fitting reward

    Money9August 2, 2021/5:01 PM IST
  • Five changes from this month that will impact your wallet

    While ICICI Bank has increased the chequebook charges from August, the CBDT has announced further tax filing relaxation

    Money9August 2, 2021/4:44 PM IST
  • K M Birla offers to hand over Vodafone Idea stake to government

    In a letter dated 7 June, the billionaire businessman extended the offer to Cabinet Secretary Rajiv Gauba

    Money9August 2, 2021/4:10 PM IST
  • HR practices for a post-Covid workplace

    Many firms are redesigning their HR policies keeping employee benefits at the top of the mind.

    Money9August 2, 2021/3:55 PM IST
  • Critical illness cover: Should you buy it with health or life insurance?

    Experts always suggest opting for a standalone critical illness policy alongside a comprehensive health insurance plan

    Noopur PraveenAugust 2, 2021/3:23 PM IST
  • Glenmark Life Sciences and Rolex Rings IPO: Know the GMPs and allotment status

    Glenmark Life Sciences is quoting at a premium of Rs 90 over its issue price of Rs 720 while Rolex Rings is commanding a GMP of Rs 470 per share

    Money9August 2, 2021/2:47 PM IST
  • This stock turned Rs 10,000 to over Rs 2,50,000 in 10 years

    Analysts hold mixed views on SRF post Q1 results. IIFL Securities has a 'Buy' call on the company with a price target of Rs 9,435

    Money9August 2, 2021/2:40 PM IST
  • ←
  • 1
  • …
  • 1,125
  • 1,126
  • 1,127
  • 1,128
  • 1,129
  • …
  • 2,222
  • →

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • बैंक हड़ताल से मध्यप्रदेश में 3,000 करोड़ रुपये से ज्यादा का कारोबार प्रभावित : संगठन
  • भारत-ईयू ने की एफटीए की घोषणा; प्रधानमंत्री मोदी ने इसे अब तक का सबसे बड़ा व्यापार समझौता बताया
  • बैंकों में हड़ताल से मंगलवार को कामकाज प्रभावित होने की आशंका
  • भारत – यूरोपीय संघ के बीच मुक्त व्यापार समझौते पर वार्ता पूरी हुई: वाणिज्य सचिव
  • मदर ऑफ ऑल डील भारत के लिए फायदेमंद, बढ़ेगा एक्सपोर्ट और रोजगार
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2026 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close